House Votes to Block Feds From Interfering With State-Legalized Marijuana

“It is the start of the end of a national prohibition,” said Democratic Rep. Jared Polis of Colorado.

Drug of choice?
National Journal
May 30, 2014, 4:06 a.m.

Us­ing states’ rights as a bi­par­tis­an ral­ly­ing cry, the House voted 219-189 early Fri­day to pro­hib­it the Justice De­part­ment from spend­ing fed­er­al tax­pay­er dol­lars to con­duct raids or oth­er­wise in­ter­fere with med­ic­al-marijuana activ­it­ies that are leg­al in the states.

The move came shortly after mid­night with pas­sage of an amend­ment to the $51.2 bil­lion an­nu­al Com­merce, Sci­ence, Justice, and Re­lated Agen­cies spend­ing bill, sponsored by GOP Rep. Dana Rohra­bach­er of Cali­for­nia. Two oth­er amend­ments to block the Drug En­force­ment Ad­min­is­tra­tion from in­ter­fer­ing with in­dus­tri­al hemp op­er­a­tions leg­al­ized by states also were ap­proved.

“To­geth­er we have made his­tory in the battle for com­mon­sense marijuana law re­forms. It is the start of the end of a na­tion­al pro­hib­i­tion,” gushed one co­spon­sor, Demo­crat­ic Rep. Jared Pol­is of Col­or­ado, in a tweet after the vote.

In all, 49 Re­pub­lic­ans and 170 Demo­crats sup­por­ted the amend­ment, with 23 mem­bers not cast­ing a vote. The en­tire ap­pro­pri­ations bill was it­self later ap­proved 321-87.

House re­cords show Speak­er John Boehner did not vote on the amend­ment, which is not un­com­mon. Ma­jor­ity Lead­er Eric Can­tor, Ma­jor­ity Whip Kev­in Mc­Carthy, and GOP Con­fer­ence Chair Cathy Mc­Mor­ris Rodgers voted against the meas­ure. Minor­ity Lead­er Nancy Pelosi voted in fa­vor of the amend­ment, as did Minor­ity Whip Steny Hoy­er and Demo­crat­ic Caucus Chair­man Xavi­er Be­cerra.

The Sen­ate has yet to vote on its ver­sion of the same spend­ing bill. It was not cer­tain Fri­day that a sim­il­ar amend­ment would be at­tached to that bill. Any dif­fer­ences between the House and Sen­ate meas­ures would have to be re­con­ciled in a two-cham­ber con­fer­ence.

Dur­ing a news con­fer­ence hours after the vote, sev­er­al law­makers be­hind the amend­ment ad­mit­ted sur­prise over its pas­sage. Said Rohra­bach­er, “It is vi­tally im­port­ant for the Amer­ic­an people to speak up now about med­ic­al mari­ujana.” He urged them to “get ahold” of their rep­res­ent­at­ives in Wash­ing­ton, “and let them know how you feel about (Fri­day morn­ing’s) vote.”

At the same time, Rohra­bach­er, Pol­is and oth­er amend­ment co­spon­sors would not, or could not, identi­fy a spe­cif­ic sen­at­or who might cham­pi­on the meas­ure in that cham­ber. Adding doubt about the amend­ment’s fate is that none of the 12 an­nu­al spend­ing bills have yet passed both the House and Sen­ate for the fisc­al year that be­gins on Oct. 1.

With time run­ning out, the budget pro­cess could again be short-cir­cuited this elec­tion year to­ward a more gen­er­al­ized “om­ni­bus” bill or short-term con­tinu­ing res­ol­u­tion as a de­fault to keep agen­cies fun­ded in­to the new fisc­al year. Those paths likely would not in­cor­por­ate such a con­tro­ver­sial amend­ment.

Still, Pol­is said “the will of the House” in sup­port­ing the amend­ment is at least “of­fi­cially on the re­cord” and that, in it­self, will help build mo­mentum. He said Con­gress is not lead­ing the way, but only “catch­ing up” with some states and loc­al­it­ies.

More than half the states — at least 26 and the Dis­trict of Columbia — have already en­acted laws al­low­ing pa­tients ac­cess to some form of med­ic­al marijuana or a de­riv­at­ive. “The train has already left the sta­tion,” ar­gued one of the amend­ment’s oth­er co­spon­sors, Demo­crat­ic Rep. Earl Blumenauer of Ore­gon, in a short de­bate on the House floor be­fore the vote.

Rohra­bach­er on the House floor ap­pealed for law­makers to make good on their pro­fessed re­spect for state sov­er­eignty un­der the 10th Amend­ment’s lim­it­a­tions on fed­er­al power and to show that “we really do be­lieve in re­spect­ing the doc­tor-pa­tient re­la­tion­ship.”

Rohra­bach­er also cited a re­cent Pew sur­vey that found 76 per­cent of Amer­ic­ans — in­clud­ing 69 per­cent of Re­pub­lic­ans and 79 per­cent of Demo­crats — think that people con­victed of pos­sess­ing small amounts of marijuana should not have to serve time in jail.

“Des­pite over­whelm­ing shift in pub­lic opin­ion, the fed­er­al gov­ern­ment con­tin­ues its hard line of op­pres­sion against med­ic­al marijuana,” Rohra­bach­er said. But he said the DEA would be blocked from us­ing any money in this ap­pro­pri­ations bill to con­duct raids on state-leg­al med­ic­al-marijuana op­er­a­tions or dis­pens­ar­ies, or oth­er­wise in­ter­fere with state med­ic­al-marijuana laws or doc­tors or pa­tients abid­ing by them.

Not all law­makers who spoke on the House floor were sup­port­ive, however.

Rep. Frank Wolf, a Vir­gin­ia Re­pub­lic­an, cited op­pos­i­tion to med­ic­al marijuana from a list of med­ic­al or­gan­iz­a­tions, in­clud­ing the Amer­ic­an Med­ic­al As­so­ci­ation and the Amer­ic­an Can­cer So­ci­ety. And two House mem­bers who are doc­tors, Re­pub­lic­an Reps. John Flem­ing of Louisi­ana and Andy Har­ris of Mary­land, also spoke out against it.

“First, it’s the camel’s nose un­der the tent,” said Har­ris. He went on to ex­plain, quot­ing from a DEA re­port this month, that or­gan­izers be­hind the med­ic­al-marijuana move­ment are not really con­cerned with marijuana as medi­cine, or such things as ap­pro­pri­ate dos­ing re­gi­mens. Rather, he said, that study says back­ers see it as a step to­ward leg­al­iz­ing re­cre­ation­al marijuana.

Flem­ing ar­gued that ar­gu­ments for leg­al­iz­a­tion, even for medi­cin­al use, should not be made “on the backs of our kids and our grandkids — this is dan­ger­ous for them.” He cited stud­ies that show health risks.

But a third House mem­bers who is a doc­tor, Re­pub­lic­an Rep. Paul Broun of Geor­gia, said that while marijuana is ad­dict­ive if used im­prop­erly, there are val­id med­ic­al reas­ons to use marijuana or ex­tracts un­der the dir­ec­tion of a doc­tor. “It’s ac­tu­ally less dan­ger­ous than some nar­cot­ics pre­scribed all over the coun­try,” said Broun, who also de­scribed this as a states-rights is­sue.

“We need to re­serve the states’ powers un­der the Con­sti­tu­tion,” he said.

Though it re­mains un­cer­tain what the Sen­ate will do, one group out­side Con­gress that has been lob­by­ing in sup­port of the meas­ure since first in­tro­duced in 2003 was de­clar­ing vic­tory.

“Con­gress is of­fi­cially pulling out of the war on med­ic­al-marijuana pa­tients and pro­viders,” said Dan Riffle, dir­ect­or of fed­er­al policies for the Marijuana Policy Pro­ject, in a state­ment.

Riffle said it re­ceived more sup­port from Re­pub­lic­ans than ever be­fore, and that, “It is re­fresh­ing to see con­ser­vat­ives in Con­gress stick­ing to their con­ser­vat­ive prin­ciples when it comes to marijuana policy. Re­pub­lic­ans in­creas­ingly re­cog­nize that marijuana pro­hib­i­tion is a failed big gov­ern­ment pro­gram that in­fringes on states’ rights.”

“This is a his­tor­ic vote, and it’s yet an­oth­er sign that our fed­er­al gov­ern­ment is shift­ing to­ward a more sens­ible marijuana policy,” he said.

What We're Following See More »
Trump Delays Tariffs on Japanese and European Cars
2 days ago
Trump Unveils New Immigration Proposal
3 days ago
Trump Jr. Agrees to Testify in the Senate
5 days ago

"Donald Trump Jr. has struck a last minute deal to comply with a subpoena from the Senate Intelligence Committee ... Trump Jr. will sit for an interview some time in mid-June for between two and four hours, with the scope limited to five or six topics pertaining to his communications with Russian officials. This will be the last time Trump Jr. has to testify before the Senate Intelligence Committee, according to the terms of the deal."

China Hits Back with Tariffs on $60B in U.S. Goods
6 days ago
China Raising Tariffs
6 days ago

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.